U.S. Markets close in 3 hrs 8 mins
  • S&P 500

    4,462.62
    -18.08 (-0.40%)
     
  • Dow 30

    34,696.68
    -117.71 (-0.34%)
     
  • Nasdaq

    15,110.08
    -51.45 (-0.34%)
     
  • Russell 2000

    2,249.73
    -25.88 (-1.14%)
     
  • Crude Oil

    69.39
    +1.04 (+1.52%)
     
  • Gold

    1,790.70
    -7.80 (-0.43%)
     
  • Silver

    23.95
    -0.38 (-1.58%)
     
  • EUR/USD

    1.1823
    -0.0025 (-0.2128%)
     
  • 10-Yr Bond

    1.3290
    +0.0250 (+1.92%)
     
  • Vix

    17.96
    -0.18 (-0.99%)
     
  • GBP/USD

    1.3773
    -0.0013 (-0.0909%)
     
  • USD/JPY

    110.2260
    -0.0330 (-0.0299%)
     
  • BTC-USD

    48,024.77
    -187.89 (-0.39%)
     
  • CMC Crypto 200

    1,233.20
    -0.08 (-0.01%)
     
  • FTSE 100

    7,095.53
    -53.84 (-0.75%)
     
  • Nikkei 225

    30,181.21
    +265.07 (+0.89%)
     

Petros Pharmaceuticals to Present at the Access to Giving Virtual Investor Conference on July 14, 2021

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, July 12, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced that President and Chief Commercial Officer Fady Boctor will present a corporate overview at the Access to Giving Virtual Investor Conference being held July 13 – 15, 2021.

Mr. Boctor will deliver his corporate presentation on July 14 at 3:30pm ET.

To receive additional information, request an invitation or to schedule a one-on-one meeting, please email angie.goertz@issuerdirect.com.

Investors can register here.

About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/petros-pharmaceuticals-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-14-2021-301331250.html

SOURCE Petros Pharmaceuticals, Inc.